News & stories

Story | Sep 18, 2023

The long and winding road to affordable access to a key TB drug

Christophe Perrin, the MSF Access Campaign‘s TB advocacy pharmacist, discusses the need for secure affordable access to improved TB medicines.

News | Sep 12, 2023

J&J and Cepheid must expand access to TB drug and tests

TB is curable but remains the world’s leading infectious disease killer as pharma corporations stand in the way of affordable medical tools

Story | Mar 23, 2023

How to end TB: Teach it at school

MSF has developed a TB education curriculum that empowers educators and learners to become TB advocates.

News | Mar 23, 2023

MSF applauds rejection of J&J attempt to extend TB drug patent

The rejection of the salt form of bedaquiline is welcome news for people with drug-resistant tuberculosis.

News | Dec 21, 2022

MSF trial finds better treatment for people with TB

Results published in the New England Journal of Medicine today show that a much shorter treatment regimen for drug-resistant TB is safer and cured almost 90 percent of patients

News | Apr 22, 2022

South Africa: MSF responds to devastating floods as people struggle to access clean water

News | Mar 24, 2022

World TB Day: MSF's community-based project in South Africa informs new global guidance

Children living with TB should be cared for in their communities.

Story | Dec 01, 2021

World AIDS Day 2021: Bringing care to remote communities in South Africa

News | Oct 20, 2021

MSF tuberculosis clinical trial finds shorter, more effective, and safer treatment

News | Oct 18, 2021

EndTB clinical trial for multidrug-resistant tuberculosis concludes enrollment